Gopalan Narayanan
Overview
Explore the profile of Gopalan Narayanan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
401
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rousseau C, Maciulaitis R, Sladowski D, Narayanan G
Front Med (Lausanne)
. 2018 Jun;
5:158.
PMID: 29911104
Advanced therapy medicinal products (ATMPs), ., cell and gene therapy products, is a rapidly evolving field of therapeutic development. A significant proportion of the products are being developed by academia...
2.
3.
Narayanan G, Cossu G, Galli M, Flory E, Ovelgonne H, Salmikangas P, et al.
Hum Gene Ther Clin Dev
. 2014 Mar;
25(1):1-6.
PMID: 24649836
Gene therapy is a rapidly evolving field that needs an integrated approach, as acknowledged in the concept article on the revision of the guideline on gene transfer medicinal products. The...
4.
Melchiorri D, Pani L, Gasparini P, Cossu G, Ancans J, Borg J, et al.
Nat Rev Drug Discov
. 2013 Aug;
12(9):719.
PMID: 23954897
No abstract available.
5.
Aiuti A, Cossu G, de Felipe P, Galli M, Narayanan G, Renner M, et al.
Hum Gene Ther Clin Dev
. 2013 Jul;
24(2):47-54.
PMID: 23862696
In the European Union, the Committee for Advanced Therapies of the European Medicines Agency takes the lead in the scientific assessment for marketing authorization applications for advanced therapy medicinal products,...
6.
Weise M, Bielsky M, De Smet K, Ehmann F, Ekman N, Giezen T, et al.
Blood
. 2012 Oct;
120(26):5111-7.
PMID: 23093622
Biosimilar medicinal products (biosimilars) have become a reality in the European Union and will soon be available in the United States. Despite an established legal pathway for biosimilars in the...
7.
Weise M, Bielsky M, De Smet K, Ehmann F, Ekman N, Narayanan G, et al.
Nat Biotechnol
. 2011 Aug;
29(8):690-3.
PMID: 21822237
No abstract available.
8.
Goldring C, Duffy P, Benvenisty N, Andrews P, Ben-David U, Eakins R, et al.
Cell Stem Cell
. 2011 Jun;
8(6):618-28.
PMID: 21624806
Unprecedented developments in stem cell research herald a new era of hope and expectation for novel therapies. However, they also present a major challenge for regulators since safety assessment criteria,...
9.
Schneider C, Salmikangas P, Jilma B, Flamion B, Todorova L, Paphitou A, et al.
Nat Rev Drug Discov
. 2010 Mar;
9(3):195-201.
PMID: 20190786
Advanced therapy medicinal products (ATMPs), which include gene therapy medicinal products, somatic cell therapy medicinal products and tissue-engineered products, are at the cutting edge of innovation and offer a major...